Xenon Pharmaceuticals
XENE
#3703
Rank
NZ$5.96 B
Marketcap
NZ$77.23
Share price
-0.93%
Change (1 day)
7.24%
Change (1 year)

Xenon Pharmaceuticals (XENE) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$14.42 Million

According to Xenon Pharmaceuticals's latest financial reports the company's total debt is NZ$14.42 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Xenon Pharmaceuticals - Total debt on balance sheet (from 2013 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$15.98 M-7.28%
2023-12-31NZ$17.24 M4.9%
2022-12-31NZ$16.43 M35.96%
2021-12-31NZ$12.08 M163.12%
2020-12-31NZ$4.59 M-81.19%
2019-12-31NZ$24.42 M9.12%
2018-12-31NZ$22.38 M133.64%
2017-12-31NZ$9.58 M
2012-12-31NZ$2.02 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Coherus BioSciences
CHRS
NZ$70.48 M 388.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
NZ$30.6 M 112.18%๐Ÿ‡บ๐Ÿ‡ธ USA